Centene (NYSE:CNC) Releases FY 2025 Earnings Guidance

Centene (NYSE:CNC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 7.250- for the period, compared to the consensus earnings per share estimate of 7.950. The company issued revenue guidance of -.

Centene Stock Performance

Shares of Centene stock opened at $58.88 on Wednesday. The company has a 50 day moving average price of $60.09 and a 200 day moving average price of $62.90. The firm has a market capitalization of $29.21 billion, a P/E ratio of 9.44, a PEG ratio of 0.80 and a beta of 0.40. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. Centene has a 52 week low of $55.03 and a 52 week high of $80.59.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.31. The business had revenue of $40.81 billion during the quarter, compared to analysts’ expectations of $38.78 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The business’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $0.45 earnings per share. Sell-side analysts expect that Centene will post 6.86 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Barclays raised their price objective on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research note on Friday, December 13th. JPMorgan Chase & Co. reissued an “overweight” rating and set a $75.00 price target (down from $80.00) on shares of Centene in a research report on Tuesday, December 17th. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Truist Financial reduced their target price on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a report on Friday, December 13th. Finally, UBS Group raised shares of Centene from a “neutral” rating to a “buy” rating and upped their price target for the company from $79.00 to $80.00 in a report on Friday, December 13th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $79.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.